Last reviewed · How we verify

NCT04361292

Ejaculatory Abstinence in IUI Cycles

Completed NA Last updated 27 April 2020
What this trial tests

NA trial testing INTRAUTERINE INSEMINATION in Infertility in 120 participants. Completed in 29 February 2020.

Timeline
1 January 2019
Primary endpoint
30 December 2019
29 February 2020

Quick facts

Lead sponsorPamukkale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment120
Start date1 January 2019
Primary completion30 December 2019
Estimated completion29 February 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

Adults 20 to 40, any sex, with Infertility or Spermatozoa. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intrauterine insemination (IUI) combined with ovarian stimulation, has been an extensively used procedure for the treatment of patients with unexplained infertility. The aim of this study was to report the effect of ejaculatory abstinence on sperm DNA fragmentation and pregnancy rates in IUI cycles, as well as the correlation between the two.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of ejaculatory abstinence period on sperm DNA fragmentation and pregnancy outcome of intrauterine insemination cycles:  A prospective randomized study.
    Kabukçu C, Çil N, Çabuş Ü, Alataş E. · · 2021 · cited 15× · PMID 32902676 · DOI 10.1007/s00404-020-05783-0

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04361292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing